If you have migraine, you have probably learned about a treatment two years after the trial came out, from a comment section. That gap is not your fault. The research is published across dozens of journals, most of it sits behind paywalls, and the small slice that gets picked up by news outlets is usually the splashiest finding of the month rather than the most useful one.

Today in Migraine Science was built to close that gap. Every day, the newest migraine papers get read, summarized in language a person without a research background can follow, and posted with a direct link to the source. Below is what is on the page, what to look for in any migraine research source, and how it compares to the other places people go.

Why keeping up with migraine research is so hard

Migraine is one of the most common neurological conditions in the world and one of the most actively researched. In any given week there are new randomized trials, cohort studies, imaging work, biomarker papers, guideline updates, and regulatory decisions. That volume is good news. It is also the reason nobody can keep up.

Four things get in the way:

• Volume. New migraine papers appear across neurology, headache, pain, obstetrics, pediatrics, psychiatry, and general medicine journals. No single journal covers the field.
• Paywalls. A lot of it is not readable without an institutional login, so even motivated patients hit a wall at the abstract.
• Language. Abstracts are written for other researchers. "Least squares mean change from baseline in monthly migraine days" is precise, and it is not how anyone talks.
• Selection. When migraine research does make the news, the story is usually the one with the best headline, not the one that changes what a person might ask their neurologist about.

The result is a strange situation where the science is public, the summaries are not, and the loudest migraine content online is on social media, where quality tends to be poor. One content analysis of the most viewed TikTok videos tagged migraine found they scored low on reliability, quality, and understandability. That study is on the page too, with a link.

What Today in Migraine Science is

Today in Migraine Science is a daily feed of new migraine research on cerebraltorque.com. It is free, there is no account, no paywall, and no newsletter signup required to read it.

Each day, new entries go up at the top of the page under that day's date. Every entry has four parts: a label for the study type, a short summary written in plain language that keeps the actual numbers, a button that goes straight to the published study, and the journal it came from. Previous days stay on the page in a collapsible archive, and there is a search box that filters the whole page, including the archive.

It is not only papers. Approvals, phase 3 topline results, guideline changes, and other headache news get their own entries when they happen. Deeper write-ups from the MigraineScience blog get linked in as well, so a study that deserves 1,500 words gets 1,500 words instead of a paragraph.

What a daily entry looks like

This is a real entry from the page, copied as it appeared:

Example entry

Notice what is in there. The study design is named up front. The sample size is given. The effect size is given as a number, in days per month, which is the unit that means something to a person with migraine. The word "barely" is doing honest work rather than selling a result. And the source is named, with a link, so anyone can check the summary against the paper.

That format holds whether the finding is exciting or disappointing. A trial that fails gets written up the same way as a trial that succeeds, because knowing a drug did not work is worth as much to a patient as knowing one did.

What to look for in a migraine research source

If you are evaluating any source of migraine research news, including this one, these are the things that separate useful from useless.

1. It updates on a real schedule

Research does not arrive quarterly. A source that posts once a month is a digest, and a digest is fine, but it means a finding can sit unmentioned for weeks. Daily posting means the gap between publication and plain-language summary is measured in days.

2. Every claim links to the primary source

A summary you cannot check is a rumor with better formatting. Every entry should link to the study itself, ideally to the publisher's page rather than a database record, so you can read the methods, the funding statement, and the limitations if you want to.

3. It keeps the numbers

"A new study shows promise" tells you nothing. "Cut monthly headache days from 22.8 to 14.6 over six months in 53 people" tells you the size of the effect, the timeframe, and how much weight to put on it. Numbers are what make a summary actionable in a conversation with your clinician.

4. It names the study design

A randomized trial, a cohort study, a case series, and a laboratory model are not interchangeable, and the difference decides how much you should update your beliefs. A source that labels study type at the top is telling you how to weigh what follows before you read it.

5. It says what the study cannot show

Most migraine research is observational, which means it can show association and not cause. Good summaries say so. Look for caveats about aura, about correlation, about small samples, and about findings that came from a lab model rather than from people.

6. It covers more than papers

Approvals, phase 3 topline announcements, label changes, and guideline updates change care faster than most individual studies do. A research feed that ignores regulatory news is missing the part most likely to affect your prescription.

7. The archive is searchable

Research reading is rarely linear. You hear a drug name at an appointment and want to know what has come out about it. An on-page search that filters both today's entries and the archive turns a feed into a reference.

8. The science is not attached to a sales pitch

If every summary conveniently supports a product, the summaries are marketing. The daily entries on Today in Migraine Science link to journals and nothing else, including the ones covering treatments nobody sells.

How it compares to the alternatives

Every option below is useful for something. The question is what you are trying to do.

The row that does not exist anywhere else is the first one. Plenty of places do one or two of daily, plain language, and sourced. I have not found another site that does all three for migraine, every day. That is the whole reason the page was built.

Who it is for

• People with migraine who want to know what is actually coming and what to bring up at their next appointment.
• Clinicians who treat headache but do not have time to scan seven journals a week.
• Residents, students, and trainees who need a running sense of where the field is going.
• Advocates, writers, and journalists who need an accurate starting point with the citation already attached.
• Caregivers trying to understand a condition someone they love has.

How to use it

• Bookmark the page. Checking it takes under two minutes on most days.
• Use the search box before an appointment. Type a drug name, a symptom, or a comorbidity and the page filters itself, archive included.
• Open the archive when you want context. Previous days sit under "Previous days" as collapsible entries.
• Click through on anything that matters to you. The summary is a starting point. The paper is the source.
• Bring the numbers to your clinician, not the conclusion. "This trial cut monthly migraine days by about four" is a better conversation opener than "I read about a new drug".

The rest of the Cerebral Torque library

The daily page is the front door. Behind it there is a larger free library, all of it built on the same rule that claims get sources.

• The Migraine Resource Hub. Every article organized by topic, including preventive treatment, cardiovascular risk, hormones, special populations, and nutraceuticals.
• The MigraineScience blog. Longer write-ups of single papers, like what the atogepant data actually shows, screen time and migraine across 22 studies, and whether ginger holds up when the evidence is graded.
• Find a headache specialist. Useful given how few counties have one.
• The newsletter. The same work delivered to an inbox, read by headache specialists as well as patients.
• YouTube and Instagram. The most recent videos and posts are embedded at the bottom of the daily page.

Frequently asked questions

This article is for general information and education. It is not a substitute for personalized medical advice, diagnosis, or treatment. Talk to your own clinician about your care. Summaries of published research describe what a study reported and do not mean a treatment is right for you.